1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Real-time Estimate Cboe BZX  -  12:19 2022-06-28 pm EDT
142.92 USD   -1.68%
06/27INSIDER SELL : Moderna
MT
06/27US grapples with whether to modify COVID vaccine for fall
AQ
06/27INSIDER SELL : Moderna
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna CEO to Exercise 2013 Option, Donate Funds to Charity

05/24/2022 | 06:41am EDT

By Colin Kellaher


Moderna Inc. on Tuesday said its chief executive, Stephane Bancel, plans to fully exercise an option granted in 2013 to buy nearly 4.59 million shares at 99 cents apiece and to donate proceeds from the exercise to charitable causes.

The Cambridge, Mass., vaccine maker said the option would be forfeited if not exercised by August 2023, adding that Mr. Bancel previously hasn't exercised any stock options.

In a blog post on Moderna's website, Mr. Bancel said he expects to make a charitable donation of around $355 million after paying about $280 million in taxes, assuming Moderna shares are trading at around $140.

In an effort to avoid a significant number of shares coming to the market at once, Mr. Bancel said he plans to buy 40,000 shares each Wednesday and Thursday starting this week until he has fully exercised the option.


Write to Colin Kellaher at colin.kellaher@wsj.com


(END) Dow Jones Newswires

05-24-22 0841ET

All news about MODERNA, INC.
06/27INSIDER SELL : Moderna
MT
06/27US grapples with whether to modify COVID vaccine for fall
AQ
06/27INSIDER SELL : Moderna
MT
06/26Moderna Seeks Swissmedic's Approval Extension For COVID-19 Jab Against Omicron
MT
06/25Pfizer says tweaked COVID-19 shots boost omicron protection
AQ
06/24INSIDER SELL : Moderna
MT
06/24Moderna COVID-19 shots now an option for older kids in US
AQ
06/24U.S. CDC backs Moderna's COVID vaccine for teens, older children
RE
06/24The next COVID booster shots will likely be updated for Omicron
RE
06/24Sanofi, GSK variant-specific COVID shot found effective against Omicron
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 22 079 M - -
Net income 2022 11 509 M - -
Net cash 2022 18 531 M - -
P/E ratio 2022 5,33x
Yield 2022 -
Capitalization 57 818 M 57 818 M -
EV / Sales 2022 1,78x
EV / Sales 2023 3,58x
Nbr of Employees 2 700
Free-Float 90,6%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 145,36 $
Average target price 213,67 $
Spread / Average Target 47,0%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-43.20%57 385
IQVIA HOLDINGS INC.-24.22%40 468
LONZA GROUP AG-32.64%39 851
SEAGEN INC.16.00%33 010
CELLTRION, INC.-11.36%18 371
ICON PUBLIC LIMITED COMPANY-28.76%17 936